Bad news for Johnson & Johnson's vaccine
from a team of New York University researchers found the one-shot Johnson & Johnson vaccine is far less effective at preventing coronavirus infections from the Delta variant and other mutated forms of the virus than from earlier strains, a concerning find since the Delta variant now accounts for almost all U.S. Covid-19 cases....
Clinical trials put the J&J vaccine's efficacy at around 66% against the original coronavirus strain, while the two-shot Pfizer and Moderna vaccines were more than 90% effective.Tuesday the Delta variant now makes up around 83% of all Covid cases in the United States.published by Johnson & Johnson, which suggested the vaccine was effective against Delta and other new variants.
. The number actually represents just a small slice of around 161.5 million Americans who have been fully vaccinated.Rising cases, hospitalizations and deaths across the U.S. are fueling concerns about another major Covid spike. Numerous cities and localities are now urging all residents to wear
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
J&J Vaccine Less Effective Against Variants: StudyA new study says the one-dose Johnson & Johnson vaccine provides less protection against the Delta and Lamba variants than against the original COVID-19 strain.
Leer más »
Johnson & Johnson COVID-19 vaccine may not perform as well against Delta variant, says studyThe study, which examined blood samples in a laboratory setting and has not yet been peer-reviewed, suggests that anyone who received the J&J vaccine may...
Leer más »
Is J&J's COVID-19 shot good enough? Experts say yes but want more data.Studies suggest the J&J vaccine may provide somewhat less protection, particularly against the delta variant, which now accounts for more than 80% of COVID-19 cases across the United States.
Leer más »
J&J forecasts $2.5B in revenue from Covid vaccine sales during 2021Although Johnson & Johnson raised its 2021 revenue estimates, its vaccine sales outlook pales in comparison with its peers, reflecting the widening gap in the global vaccine race.
Leer más »
Does America face a slowdown in economic growth?Even if vaccines eliminate the need to return to strict measures, consumers may become too anxious to visit bars and restaurants
Leer más »
If you got the Johnson & Johnson vaccine, do you need another dose?There's growing anxiety over the highly contagious delta variant in the U.S.
Leer más »